Share Article

These cases are among more than 270 testosterone treatment lawsuits currently pending in federal court, all of which allege low testosterone therapies increase a man’s risk for heart attacks, strokes, blood clots and other serious cardiovascular complications.

Our Firm is currently investigating claims on behalf of a number of testosterone patients who allegedly suffered the same types of cardiovascular complications included in these lawsuits.

Past News Releases

The federal court overseeing hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) filed against the manufacturers of AndroGel, Axiron, and other low testosterone therapies has refused a bid by defendants to dismiss 39 cases pending in the litigation, Bernstein Liebhard LLP reports. According to an Order issued on December 23, 2014 in the U.S. District Court, Northern District of Illinois, the defense had argued that plaintiffs failed to sufficiently allege that testosterone replacement drugs had caused their cardiovascular injuries, asserting, among other things, that studies cited in their complaints had been discredited. But the Court pointed out that the plaintiffs had cited both studies and recent regulatory action that require all prescription testosterone treatments to carry warnings about a potential risk for venous thromboembolism. As such, the Court found that “the plaintiffs have sufficiently alleged general causation.” (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is currently investigating claims on behalf of a number of testosterone patients who allegedly suffered the same types of cardiovascular complications included in these lawsuits. We are monitoring developments in the federal litigation closely, and are encouraged to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by AndroGel, Axiron, Testim and other low testosterone treatments.

Testosterone Litigation
Court records indicate that the multidistrict litigation underway in Illinois was established this past June, after the U.S. Food &amp; Drug Administration (FDA) announced on January 31, 2014 that it had launched a review of the medications. Since then, a panel of FDA advisors has recommended that the drugs’ labels be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other issues commonly experienced by men as they age. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

According to court documents, more than 270 testosterone lawsuits are currently pending in the federal litigation, all of which were filed on behalf of men who suffered heart attacks, strokes, blood clots and other life-threatening cardiovascular events due to their use of low testosterone therapies. Among other things, the complaints allege that the manufacturers of these drugs concealed their potentially dangerous side effects from the public, and failed to warn doctors and patients about those risks. Plaintiffs further allege that sales of the medications were driven by misleading marketing claims that induced many healthy men to use the drugs in the absence of a true medical need.

Men who used prescription testosterone treatments may be entitled to compensation if they experienced heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other cardiovascular complications allegedly related to their use. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092